entertainment -WSS

entertainment

author：fashion 2025-10-06 07:54:39 - browse：11

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Patient advocates sound warning on FDA proposal on salt intake

WSS

Kidney transplant patients stopped immunosuppressants in trial

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Beware the threat of staffing cuts at the CDC

Congress must give Medicare recipients genetic counseling access

Living with Hashimoto's and celiac disease, and med school, too

After Sarepta trial failure, Duchenne families brace for more debate

hotspot

entertainment

focus

Supreme Court strikes down use of affirmative action

Kidney transplant patients stopped immunosuppressants in trial

Guidelines to prevent youth baseball injuries need more muscle

Explaining an after

Guidelines to prevent youth baseball injuries need more muscle

After Sarepta trial failure, Duchenne families brace for more debate

Duchenne breakthrough therapy leaves behind pioneering families

As Maui death toll rises, number of missing remains unclear

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Clinical trials must include more disabled people

knowledge

Humans aren't the only ones with an imagination. Rats have it too

Travis Kelce and the trap of celebrity vaccine endorsements

Sarepta Duchenne therapy fails to meet primary endpoint in trial

The pain doctors face in trying to build their families

Kidney transplant patients stopped immunosuppressants in trial

Explaining an after

hotspot

focus

focus

explore